Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

This study has been completed.
Information provided by:
Hospital de Sao Sebastiao
ClinicalTrials.gov Identifier:
First received: May 4, 2009
Last updated: NA
Last verified: May 2009
History: No changes posted

Primary Purpose:

  • To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®

Secondary Purpose:

  • Subjective evaluation of symptomatology
  • Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses

Dry Eye Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Efficacy Comparative Study Between Tears Again®, o Opticol® e o Optive® in Clinical and Symptomatology Treatment of Dry Eye Syndrome in Contact Lens Wearers and/or Computers Users

Resource links provided by NLM:

Further study details as provided by Hospital de Sao Sebastiao:

Enrollment: 27
1Tears Again/Control
4Tears Again/Opticol
5Tears Again/Optive


Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Administrative staff of the hospital with more than 4 hours/day computer use and contact lens wearers


Inclusion Criteria:

  • Informed Consent signed
  • Age >18 years and < 55 years
  • Daily wearer of soft contact lens and/or daily (> 4 hours/day) computer user

Exclusion Criteria:

  • Dry eye Syndrome other than of evaporative etiology, according to DEWS
  • Ocular or systemic disease that can affect the normal tear film
  • Pregnancy or pregnancy risk (no contraceptive method), lactation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00893243

Serviço de Oftalmologia, Hospital de São Sebastião
Santa maria da Feira, Portugal, 4520-211
Sponsors and Collaborators
Hospital de Sao Sebastiao
Principal Investigator: Lilianne Duarte, MD Ophthalmologist
Study Director: José Salgado-Borges, PhD Ophthalmology Department Director
  More Information

No publications provided

Responsible Party: Dr Lilianne Duarte, MD, Ophthalmologist
ClinicalTrials.gov Identifier: NCT00893243     History of Changes
Other Study ID Numbers: HSS-01-08
Study First Received: May 4, 2009
Last Updated: May 4, 2009
Health Authority: Portugal: National Pharmacy and Medicines Institute

Additional relevant MeSH terms:
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Lacrimal Apparatus Diseases
Eye Diseases
Conjunctival Diseases
Corneal Diseases

ClinicalTrials.gov processed this record on April 23, 2014